Acadia Pharmaceuticals Inc
ACAD
Market Cap$2.49B
Close$
$18.95
11.9% upside
Current Fair Value
11.9% upsideUndervalued by 11.9% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $2.49 Billion |
|---|---|
| Enterprise Value | $2.24 Billion |
| Dividend Yield | $0 (0%) |
| Earnings per Share | $1.37 |
| Beta | 0.54 |
| Outstanding Shares | 166,535,000 |
Return
| Return on Equity | - |
|---|---|
| Return on Assets | - |
| Return on Invested Capital | - |
Valuation & Multiples
| P/E Ratio | 10.97 |
|---|---|
| PEG | 5.13 |
| Price to Sales | 3.39 |
| Price to Book Ratio | 4.23 |
| Enterprise Value to Revenue | 2.34 |
| Enterprise Value to EBIT | 26.57 |
| Enterprise Value to Net Income | 9 |
| Total Debt to Enterprise | 0.03 |
| Debt to Equity | 0.09 |
Revenue Sources
No data
Insider Trades
ESG Score
No data
About Acadia Pharmaceuticals Inc
CEO: Uli Hacksell